Full-Time
Confirmed live in the last 24 hours
Develops medical devices for emergency care
No salary listed
Mid
No H1B Sponsorship
Sydney NSW, Australia
Candidate must have the right to work in Australia.
ZOLL Medical Corporation develops and sells medical devices and software aimed at improving emergency care and saving lives. Their products include defibrillators, monitoring systems, tools for circulation and CPR feedback, data management solutions, therapeutic temperature management devices, and ventilation equipment. These technologies assist healthcare professionals, emergency medical services (EMS), fire personnel, and even bystanders in providing effective treatment for individuals in need of resuscitation and critical care. ZOLL stands out from its competitors by offering a comprehensive range of products that enhance both clinical outcomes and operational efficiency in emergency situations. The company's goal is to advance the quality of emergency medical care and ensure that more lives are saved during critical moments.
Company Size
1,001-5,000
Company Stage
Acquired
Total Funding
$2.2B
Headquarters
null
Founded
1980
Help us improve and share your feedback! Did you find this helpful?
Casual Work Environment
Air Methods collaborated closely with ZOLL to provide direct feedback during the development of the AutoPulse NXT, which was released in 2024.
The ZOLL AR Boost(R) Insurance Discovery tool secured the #1 spot in the 2024 Insurance Discovery Solutions category.
Zoll Medical Corp. is asking a Boston federal judge to toss a proposed class action brought by medical device customers whose personal information was released during a ransomware attack last year...
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has received an Innovative Technology contract from Vizient, Inc., the nation’s largest provider-driven healthcare performance improvement company. The contract was awarded based on the recommendation of hospital experts who serve on one of Vizient’s customer-led councils, and it signifies unique qualities that potentially bring improvement to patient cardiovascular care. Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient’s Innovative Technology Program. Vizient customer-led councils identify technologies that have the potential to enhance clinical care, patient safety, healthcare worker safety, or improve business operations of healthcare organizations. “Each year, more than 258,000 patients in the U.S. access emergency rooms as a result of heart attacks,1” said Matt Rochner, TherOx General Manager
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, spółka z Grupy Asahi Kasei produkująca wyroby medyczne i powiązane oprogramowanie, ogłosiła dzisiaj, że defibrylator ZOLL AED 3® został zatwierdzony zgodnie z unijnym rozporządzeniem (UE) 2017/745 w sprawie wyrobów medycznych, zwanym w skrócie „EU MDR”. EU MDR to wprowadzone przez Unię Europejską rozporządzenie 2017/745 w sprawie wyrobów medycznych przyjęte przez Parlament Europejski i Radę w 2017 r. Celem EU MDR jest zagwarantowanie wysokich standardów bezpieczeństwa i jakości wyrobów medycznych wytwarzanych w państwach członkowskich Unii Europejskiej lub dostarczanych na ich terytorium. Firma ZOLL uzyskała właśnie oznakowanie CE swojego defibrylatora ZOLL AED 3 zgodnie z przepisami EU MDR